Education
About Us
Working with TipRanks
Follow Us
Solasia Pharma KK (JP:4597)
:4597
RESEARCH TOOLSreports
4597 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥27.00 - ¥69.00
Previous CloseN/A
Volume8.51M
Average Volume (3M)23.11M
Market Cap
€9.97B
Enterprise Value¥6.80B
Total Cash (Recent Filing)€1.06B
Total Debt (Recent Filing)€17.00M
Price to Earnings (P/E)―
Beta0.42
Next Earnings
Aug 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.34
Shares Outstanding256,109,000
10 Day Avg. Volume23,771,730
30 Day Avg. Volume23,105,506
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Solasia Pharma KK News
4597 FAQ
What was Solasia Pharma KK’s price range in the past 12 months?
Solasia Pharma KK lowest stock price was ¥27.00 and its highest was ¥69.00 in the past 12 months.
What is Solasia Pharma KK’s market cap?
Solasia Pharma KK’s market cap is €9.97B.
When is Solasia Pharma KK’s upcoming earnings report date?
Solasia Pharma KK’s upcoming earnings report date is Aug 13, 2025 which is in 3 days.
How were Solasia Pharma KK’s earnings last quarter?
Solasia Pharma KK released its earnings results on May 14, 2025. The company reported -¥1.34 earnings per share for the quarter, missing the consensus estimate of N/A by -¥1.34.
Is Solasia Pharma KK overvalued?
According to Wall Street analysts Solasia Pharma KK’s price is currently Overvalued.
Does Solasia Pharma KK pay dividends?
Solasia Pharma KK does not currently pay dividends.
What is Solasia Pharma KK’s EPS estimate?
Solasia Pharma KK’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Solasia Pharma KK have?
Solasia Pharma KK has 256,109,000 shares outstanding.
What happened to Solasia Pharma KK’s price movement after its last earnings report?
Solasia Pharma KK reported an EPS of -¥1.34 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Solasia Pharma KK?
Currently, no hedge funds are holding shares in JP:4597
Company Description
Solasia Pharma KK
Solasia Pharma KK is a specialty pharmaceutical company based in Japan, primarily focused on the development and commercialization of innovative oncology therapies and supportive care products. The company aims to address unmet medical needs in the field of cancer treatment with a strong emphasis on the Asian market. Solasia Pharma engages in the research and development of new drug candidates and collaborates with global partners to bring these therapies to market.
Technical Analysis
Sumitomo Dainippon Pharma Co
―
Chugai Pharmaceutical Co
―
Shionogi & Co
―
Takeda Pharmaceutical Co
―
Daiichi Sankyo Company
―
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
99.84% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---